Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial
about
sameAs
Statins for children with familial hypercholesterolemiaStatins for children with familial hypercholesterolemiaStandards of medical care in diabetes--2012Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosisAmbient air pollution and atherosclerosis in Los AngelesAssociation of Exposure to particular matter and Carotid Intima-Media Thickness: A Systematic Review and Meta-AnalysisBenefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesChallenges in the pharmacologic management of obesity and secondary dyslipidemia in children and adolescentsFamilial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyPediatric Statin Administration: Navigating a Frontier with Limited DataThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyStandards of medical care in diabetes--2013The UK Paediatric Familial Hypercholesterolaemia Register: preliminary dataAdolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT)Standards of medical care in diabetes--2010.The current state of dyslipidemia in Korean children and adolescents and its management in clinical practice.Familial hypercholesterolemia: A reviewUse of atorvastatin in systemic lupus erythematosus in children and adolescentsIdentification and treatment of metabolic complications in pediatric obesity.Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.Long-term pharmacotherapy for elevated low density lipoprotein levels in children: A retrospective analysisThe safety of statins in children.Optimal management of familial hypercholesterolemia: treatment and management strategiesStandards of medical care in diabetes--2011.Use of statins for dyslipidemia in the pediatric population.Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.Considering statins for cholesterol-reduction in children if lifestyle and diet changes do not improve their health: a review of the risks and benefitsAchievement of cardiovascular risk factor targets in young adults with diabetes mellitus.An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemiaMetabolic syndrome in the pediatric population: a short overviewDepressive symptoms and subclinical markers of cardiovascular disease in adolescentsLong-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence.Therapeutic approach to FSGS in children.Patterns of Lipid Lowering Therapy among Children Ages 8-20 Years.Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.Management of hereditary dyslipidaemia; the paradigm of autosomal dominant hypercholesterolaemia.Adolescent lipoprotein classifications according to National Health and Nutrition Examination Survey (NHANES) vs. National Cholesterol Education Program (NCEP) for predicting abnormal lipid levels in adulthood in a Middle East populationCardiovascular disease risk in the offspring of diabetic women: the impact of the intrauterine environment.Carotid intima-media thickness in children with CKD: results from the CKiD study.Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia.
P2860
Q24194816-B943DBE1-865F-4694-AA00-3A23ADB700D4Q24234081-3AE38D05-236E-4069-95FA-AA03611205D2Q24632533-7749CDD2-09DA-4F6D-BA61-8DF63D72B233Q24676643-818E0331-F76A-489C-9996-2DD5041908D1Q24814256-8A9FECD2-CD04-41E6-861F-571D8C92AA98Q26778973-7B4485FC-C2BA-4082-B441-785155440F79Q26853571-665DFE81-3D5B-4F12-B2BE-1CBA99A893FAQ27002669-91293C76-2524-4E6F-B598-692599C18429Q27024882-35EFE237-E766-48E2-A74E-5544D2ACD021Q28068014-652A4958-2295-4294-AC6A-531EF6FC9971Q28305315-157613D3-A36D-4136-8F3F-F8135EE8CDC7Q29620309-7C5691BD-44F6-4D7C-80C3-4535C0A74995Q31053814-B0B20DC1-E400-42E9-9EF2-AA89381A13D5Q33519176-3222B493-9794-4465-BA99-08A914D7E310Q33554238-CE1F4FAC-D242-490D-A9D2-AD7F4AAAE288Q33635194-A4F57304-3A71-412D-9E59-97F4571BCA81Q33803782-7C7E348A-A06C-487A-8242-D07E38612516Q33818710-21732BEC-44FA-4EF1-8E57-C77D421EEFBBQ33893011-4E4E8896-6C5D-4999-86EE-7EE31D8CB209Q33922922-88F6CCB5-A8BC-4652-8C56-2AFD24B75BC1Q33924782-9C3BFD58-8CB1-4665-A91D-1E73919C3690Q34342024-10A92854-49AA-4A99-A278-0A30461F986DQ34417480-84F0C3EF-4701-410B-B203-CB7A70DB33ADQ34425055-406064C8-4F1A-4C8A-8C63-C7F74BDC56E1Q34477252-986205CF-C432-4FF3-82A0-17D27019370CQ34499298-D2E515A8-DB03-42D9-9882-54AA2047C39CQ34566253-F96232CF-074F-48AD-8395-3D0767FD244DQ34620412-85626C25-443E-4C05-ACC0-9E38DAD35F7EQ34700305-DF56BDC6-5730-47ED-8BC3-382CF1CE03D9Q34985768-2A49B91B-A1F7-4581-A316-EC8B5381B109Q34988504-4C1EF499-7F4C-4662-82AB-15EF700B3E80Q35214678-9DC8879A-D36E-4ED3-9B3F-AC414752AFF7Q35614311-5BF7261E-2803-4516-9692-058BD64948D7Q35799689-49E8E0F9-85A1-4D06-8EFF-3D3F53078341Q36076131-4BFA0960-7335-422B-A891-A54EE6768912Q36270428-40BF996E-D888-4F71-81B1-88B1C177DBE7Q36335212-1D9CBCF0-9FB9-4CA7-98A1-04430B7113F4Q36361035-B3061961-09D3-460B-B735-A7C431C5DC06Q36443220-BBC9651F-CCA0-48EF-A3E6-D170D69C2940Q36484907-D916CF01-2AED-4E51-A126-247C30F57803
P2860
Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Efficacy and safety of statin ...... a randomized controlled trial
@ast
Efficacy and safety of statin ...... a randomized controlled trial
@en
Efficacy and safety of statin ...... a randomized controlled trial
@nl
type
label
Efficacy and safety of statin ...... a randomized controlled trial
@ast
Efficacy and safety of statin ...... a randomized controlled trial
@en
Efficacy and safety of statin ...... a randomized controlled trial
@nl
altLabel
Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia
@en
prefLabel
Efficacy and safety of statin ...... a randomized controlled trial
@ast
Efficacy and safety of statin ...... a randomized controlled trial
@en
Efficacy and safety of statin ...... a randomized controlled trial
@nl
P2093
P356
P1476
Efficacy and safety of statin ...... a randomized controlled trial
@en
P2093
Albert Wiegman
Barbara A Hutten
Eric de Groot
Harry R Büller
Henk D Bakker
Jessica Rodenburg
John J P Kastelein
P304
P356
10.1001/JAMA.292.3.331
P407
P577
2004-07-01T00:00:00Z